Back to BAKER BROS. ADVISORS LP

TRDA
Showing 8 of 18 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in ENTRADA THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 5.1M shares of TRDA (ENTRADA THERAPEUTICS INC), worth $64M as of 2026-Q1. TRDA represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$64M

Current Shares

5.1M

Total Value Change

-$5.3M

Total Shares Change

+206,911

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
5.1M
0.0%
$64M0.4%$11.85
0
2025-Q4
Increased
5.1M
+4.3%
$52.1M0.3%$10.09
37
2025-Q3
Unchanged
4.9M
0.0%
$28.2M0.2%$5.84
0
2025-Q2
Unchanged
4.9M
0.0%
$32.7M0.3%$6.91
0
2025-Q1
Unchanged
4.9M
0.0%
$44M0.5%$9.56
0
2024-Q4
Unchanged
4.9M
0.0%
$84.1M0.9%$17.37
0
2024-Q3
Unchanged
4.9M
0.0%
$77.8M0.8%$16.45
0
2024-Q2
Unchanged
4.9M
0.0%
$69.3M0.9%$14.25
0

Other major holders of TRDA: PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used